黄酮醇
生物利用度
化学
多酚
药理学
人口
传统医学
计算生物学
生物技术
医学
生物化学
抗氧化剂
生物
环境卫生
作者
Tomasz Przybylski,Joanna Czerniel,Jakub Dobrosielski,Maciej Stawny
出处
期刊:Molecules
[Multidisciplinary Digital Publishing Institute]
日期:2025-07-25
卷期号:30 (15): 3113-3113
被引量:11
标识
DOI:10.3390/molecules30153113
摘要
Flavonols, representing a subclass of flavonoids, are an important group of polyphenols. Their activity is associated with a number of beneficial properties, including hepatoprotective, senolytic, neuroprotective, and anticancer properties. They are found abundantly in many fruits, vegetables, and plant products, but flavonols' chemistry and structural properties result in their low bioavailability in vivo. In recent years, more and more studies have emerged that aim to increase the therapeutic potential of compounds belonging to this group, including by developing innovative nanoformulations. The present work focuses on the various steps, such as chemical analysis of the compounds, preformulation studies using drug delivery systems, preclinical studies, and finally clinical trials. Each of these elements is important not only for the innovation and efficacy of the therapy but most importantly for the patient's health. There are also a limited number of studies assessing the population concentration of flavonols in the blood; therefore, this review presents an up-to-date survey of the most recent developments, using the most important compounds from the flavonol group.
科研通智能强力驱动
Strongly Powered by AbleSci AI